Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf E Stauber

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Biomedicines|August 26, 2023
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?Katharina Staufer, Rudolf E Stauber
World Journal of Gastroenterology|August 22, 2007
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis CRudolf-E Stauber, Carolin Lackner
Nature Clinical Practice. Nephrology|April 26, 2007
Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?Peter Krisper, Rudolf E Stauber
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 21, 2006
Novel approaches for therapy of chronic hepatitis CRudolf E Stauber, Vanessa Stadlbauer
European Journal of Gastroenterology & Hepatology|November 13, 2009
Portopulmonary hypertension: short reviewRudolf E Stauber, Horst Olschewski
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2010
Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?Søren Møller, Rudolf E Stauber
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2012
BCLC--now also an internationally acclaimed prognostic system?Markus Peck-Radosavljevic, Rudolf E Stauber
Drugs|June 27, 2008
Drugs in development for hepatitis CRudolf E Stauber, Harald H Kessler
Journal of Hepatology|April 16, 2021
Reply to: "Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF"Rudolf E Stauber, Hubert Scharnagl, Gunther Marsche
Liver International : Official Journal of the International Association for the Study of the Liver|August 10, 2011
Clearing of toxic substances: are there differences between the available liver support devices?Peter Krisper, Vanessa Stadlbauer, Rudolf E Stauber
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Biomedicines|August 26, 2023
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?Katharina Staufer, Rudolf E Stauber
World Journal of Gastroenterology|August 22, 2007
Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis CRudolf-E Stauber, Carolin Lackner
Nature Clinical Practice. Nephrology|April 26, 2007
Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?Peter Krisper, Rudolf E Stauber
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 21, 2006
Novel approaches for therapy of chronic hepatitis CRudolf E Stauber, Vanessa Stadlbauer
European Journal of Gastroenterology & Hepatology|November 13, 2009
Portopulmonary hypertension: short reviewRudolf E Stauber, Horst Olschewski
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2010
Does local sympathetic atrophy contribute to splanchnic vasodilation in portal hypertension?Søren Møller, Rudolf E Stauber
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2012
BCLC--now also an internationally acclaimed prognostic system?Markus Peck-Radosavljevic, Rudolf E Stauber
Drugs|June 27, 2008
Drugs in development for hepatitis CRudolf E Stauber, Harald H Kessler
Journal of Hepatology|April 16, 2021
Reply to: "Prognostic value of HDL-related biomarkers in patients with HBV-related ACLF"Rudolf E Stauber, Hubert Scharnagl, Gunther Marsche
Liver International : Official Journal of the International Association for the Study of the Liver|August 10, 2011
Clearing of toxic substances: are there differences between the available liver support devices?Peter Krisper, Vanessa Stadlbauer, Rudolf E Stauber
Pageof 10